JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC

Clinical trial NCT06838338 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06838338
Sponsor: Jian Li
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2025-03-20
Primary completion: 2026-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.